Cardiometabolic syndrome — an emergent feature of Long COVID?
Nature reviews. Immunology
; : 1-2, 2022.
Article
in English
| EuropePMC | ID: covidwho-1863907
ABSTRACT
Large-scale clinical studies on the post-infectious impacts of SARS-CoV-2 have suggested that patients who have recovered from acute infection have increased risk for cardiometabolic syndrome-associated morbidities such as diabetes, chronic kidney disease and heart failure. Initial studies have taken the first steps towards unravelling the molecular processes that may be driving these findings, including the role of immune and inflammatory factors, but a comprehensive aetiology remains unclear. Given that cardiometabolic syndrome progression in patients with Long COVID may pose a significant global health and economic burden post pandemic, there is an emergent need to identify therapeutic targets and treatment options. Among the multi-organ complications of Long COVID, those associated with cardiometabolic syndrome were some of the most prevalent in recent studies of population-scale data. Given the potential health and economic burdens, there is an urgent need to better define the inflammatory processes involved.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Topics:
Long Covid
Language:
English
Journal:
Nature reviews. Immunology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS